NCT06417892 2025-01-14Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ AdenocarcinomaCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting60 enrolled